| Brooks Laboratories Limited will hold a board meeting on Thursday, August 13, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with a limited review report from the statutory auditors. Trading window for directors and designated persons, along with their immediate relatives and specified connected persons, remains closed since July 1, 2026, and will reopen 48 hours after the unaudited financial results are declared. |